Federal departments and agencies in the core public administration are required to make available to employees a confidential Employee Assistance Program (EAP). An EAP provides free short-term ...

AbbVie's success with Humira is a textbook example. Humira (adalimumab) is an immunosuppressant drug used to treat several autoimmune diseases, in which a patient's immune system attacks healthy ...

Not only did AbbVie’s Skyrizi claim first place in the full-year ranking with nearly $377 million spent on 20 separate ads for the drug, according to iSpot.TV’s analysis, but, with two other ...

(AP Photo/Evan Vucci) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Follow live updates on President Donald Trump’s return to Washington WASHINGTON (AP) — President Donald Trump ...

President Trump on Monday signed an executive order suspending any new U.S. foreign development assistance ... to continue the program in the same or in a modified form. . The measure encroaches ...

At the center, people can get help applying for federal assistance, speak to representatives from state and federal agencies, receive updates on their FEMA application for assistance and learn ...

ABBV-787 is under clinical development by AbbVie and currently in Phase I for Refractory Acute Myeloid Leukemia. According to GlobalData, Phase I drugs for Refractory Acute Myeloid Leukemia have a 68% ...

Read the instructions carefully and complete the application form. Step 5: Fill in the required information and pay the required category-wise application fees. Step 6: Submit the application form ...

AbbVie (NYSE:ABBV) has managed to keep its market share for its bestselling arthritis therapy, Humira, above 70%, generic drugmaker Samsung Bioepis said in a new report on Thursday as the ...

Once Humira biosimilars entered the US markets in 2023, drug revenues declined by 32% for AbbVie. Image credit: Skorzewiak / Shutterstock AbbVie executives say the company’s immunology drugs Skyrizi ...

AbbVie closed out the year on a high note as ... all 10 counted the NFL as their top TV program, according to the month’s analysis. Below, find the full data for December’s 10 biggest pharma ...

AbbVie executives say the company’s immunology drugs Skyrizi and Rinvoq are expanding their reach in the inflammatory bowel disease (IBD) as the market for Humira biosimilars heats up.